The University of Kansas Cancer Center Among the First to Offer CAR T-cell Therapy to Treat Multiple Myeloma

The University of Kansas Cancer Center is the first and only site in the region to offer CAR T-cell therapy to treat multiple myeloma, a type of blood cancer that affects about 30,000 people each year.
29-Mar-2021 2:00 PM EDT Add to Favorites

The University of Kansas Cancer Center Joins Leading Cancer Organizations to Warn Cancer Doesn’t Stop for COVID-19 and Neither Should You

The University of Kansas Cancer Center is part of a nationwide effort to resume appropriate cancer screening and treatment to prevent excess deaths.
28-Jan-2021 9:15 AM EST Add to Favorites

Cancer center is a contributor to 49 research studies at the 62nd American Society of Hematology Annual Meeting

Researchers from The University of Kansas Cancer Center are involved in the presentation of nearly 50 research studies at the 62nd American Society of Hematology (ASH) Annual Meeting.
4-Dec-2020 1:25 PM EST Add to Favorites

Researchers discover men fighting both cancer and COVID-19 at higher risk than women

Men with cancer and COVID-19 may be at significantly higher risk for severe symptoms and even death as compared to females fighting both, a University of Kansas Cancer Center research team has found.
23-Nov-2020 12:50 PM EST Add to Favorites

Are E-cigarettes Safer Than Cigarettes? Study Sheds Light on the Issue

Scientists and medical professionals have long debated whether pod e-cigarettes are a safer alternative to traditional cigarettes. A new study provides some insight.
18-Nov-2020 3:25 PM EST Add to Favorites

One year out, cancer center countdown to applying for NCI comprehensive status kicks into high gear

In one year, The University of Kansas Cancer Center will submit its application to renew its prestigious National Cancer Institute (NCI) designation in the hopes of attaining “comprehensive” status, the NCI’s highest ranking.
1-Oct-2020 11:15 AM EDT Add to Favorites

Cancer center exceeds NCORP clinical trial accrual goals

The University of Kansas Cancer Center’s status as a community site of the National Cancer Institute’s Community Oncology Research Program has been renewed after exceeding clinical trial accrual goals by more than 22% in its first year.
24-Sep-2020 12:25 PM EDT Add to Favorites

Researchers pivot from studying cancer and cystic fibrosis to launch trial of drug to fight COVID-19

The University of Kansas Medical Center announced today a trial exploring a drug intended to fight the cytokine storm common in COVID-19.
14-Aug-2020 9:00 AM EDT Add to Favorites

See All News